作者:
Infante,J.R. [1]
;
Fecher,L.A. [2]
;
Falchook,G.S. [3]
;
Nallapareddy,S. [4]
;
Gordon,M.S. [5]
;
Becerra,C. [6]
;
DeMarini,D.J. [7]
;
Cox,D.S. [8]
;
Xu,Y. ;
Morris,S.R. ;
Peddareddigari,V.G.R. ;
Le,N.T. ;
Hart,L. ;
Bendell,J.C. ;
Eckhardt,G. ;
Kurzrock,R. ;
Flaherty,K. ;
Burris,H.A. ;
Messersmith,W.A.
作者单位:
University of Colorado Cancer Center, Aurora, CO, United States
[1]
University of Pennsylvania Abramson Cancer Center, Philadelphia, PA, United States
[2]
Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN, United States
[3]
GlaxoSmithKline, Oncology, Philadelphia, PA, United States
[4]
University of Texas MD Anderson Cancer Center, Houston, TX, United States
[5]
Texas Oncology-Baylor Charles A Sammons Cancer Center, Dallas, TX, United States
[6]
Sarah Cannon Research Institute/Florida Cancer Specialists, Fort Myers, FL, United States
[7]
Pinnacle Oncology Hematology, Scottsdale, AZ, United States
[8]
发布时间
2013-11-20